O desafio da resistência à medicação antirretroviral em crianças infectadas pelo HIV-1 The challenge of antiretroviral drug resistance in HIV-1-infected childre

by Robert W. Shafer
Published 2009-04-01

Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C

by Robert W. Shafer, Severine Margeridon-Thermet
Published 2010-12-01

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance

by Soo-Yon Rhee, Philip L. Tzou, Robert W. Shafer
Published 2021-05-01

Genetic Variability of HIV-1 for Drug Resistance Assay Development

by Dana S. Clutter, Patricia Rojas Sánchez, Soo-Yon Rhee, Robert W. Shafer
Published 2016-02-01

HIV-1 subtype B protease and reverse transcriptase amino acid covariation.

by Soo-Yon Rhee, Tommy F Liu, Susan P Holmes, Robert W Shafer
Published 2007-05-01

Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing

by Marc Noguera-Julian, Emma R. Lee, Robert W. Shafer, Rami Kantor, Hezhao Ji
Published 2020-06-01

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.

by Santiago Avila-Rios, Omar Sued, Soo-Yon Rhee, Robert W Shafer, Gustavo Reyes-Teran, Giovanni Ravasi
Published 2016-01-01

Correction: More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1

by Alison F Feder, Soo-Yon Rhee, Susan P Holmes, Robert W Shafer, Dmitri A Petrov, Pleuni S Pennings
Published 2017-01-01

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1

by Alison F Feder, Soo-Yon Rhee, Susan P Holmes, Robert W Shafer, Dmitri A Petrov, Pleuni S Pennings
Published 2016-02-01

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.

by Mark A Winters, Robert M Lloyd, Robert W Shafer, Michael J Kozal, Michael D Miller, Mark Holodniy
Published 2012-01-01

Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.

by Philip L Tzou, Sergei L Kosakovsky Pond, Santiago Avila-Rios, Susan P Holmes, Rami Kantor, Robert W Shafer
Published 2020-01-01

Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequenci...

by Severine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, Tommy F Liu, Nancy Shulman, Robert W Shafer, Isabel Najera
Published 2014-01-01

Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach

by Dario Akaberi, Assar Bergfors, Midori Kjellin, Nader Kameli, Louise Lidemalm, Bhavya Kolli, Robert W. Shafer, Navaneethan Palanisamy, Johan Lennerstrand
Published 2018-01-01

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds

by Philip L Tzou, Kaiming Tao, Janin Nouhin, Soo-Yon Rhee, Benjamin D Hu, Shruti Pai, Neil Parkin, Robert W Shafer
Published 2020-09-01

Viral population estimation using pyrosequencing.

by Nicholas Eriksson, Lior Pachter, Yumi Mitsuya, Soo-Yon Rhee, Chunlin Wang, Baback Gharizadeh, Mostafa Ronaghi, Robert W Shafer, Niko Beerenwinkel
Published 2008-05-01

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis.

by Barbara A Rath, Kaveh Pouran Yousef, David K Katzenstein, Robert W Shafer, Christof Schütte, Max von Kleist, Thomas C Merigan
Published 2013-01-01

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.

by Gert U Van Zyl, Tommy F Liu, Mathilda Claassen, Susan Engelbrecht, Tulio de Oliveira, Wolfgang Preiser, Natasha T Wood, Simon Travers, Robert W Shafer
Published 2013-01-01

Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.

by Jeffrey A Johnson, Jin-Fen Li, Xierong Wei, Jonathan Lipscomb, Diane Bennett, Ashley Brant, Mian-Er Cong, Thomas Spira, Robert W Shafer, Walid Heneine
Published 2007-01-01

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.

by Vici Varghese, Elijah Wang, Farbod Babrzadeh, Michael H Bachmann, Rajin Shahriar, Tommy Liu, Svetlana Jean M Mappala, Baback Gharizadeh, W Jeffrey Fessel, David Katzenstein, Seble Kassaye, Robert W Shafer
Published 2010-06-01

Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women

by Horacio A. Duarte, Joseph B. Babigumira, Eva A. Enns, David C. Stauffer, Robert W. Shafer, Ingrid A. Beck, Louis P. Garrison, Jr., Michael H. Chung, Lisa M. Frenkel, Eran Bendavid
Published 2020-05-01